BioArctic is one of the finalists for the European Lifestars Awards in the category ”Deal of the Year (>£500m)” for its strategic collaboration with AbbVie for the continued development of BioArctic’s potential disease modifying treatment for Parkinson’s disease.
For more information see the link below: